Apr 28, 2010--AuthenTec (NASDAQ: AUTH), a leading provider of security ... Emulex is listed on the New York Stock Exchange (NYSE: ELX) and has corporate headquarters in Costa Mesa, California. News releases and other …
CHICAGO--(BUSINESS WIRE)--Today, Zacks Investment Ideas feature highlights Features: DineEquity Inc. (NYSE: DIN), Emulex Corp (NYSE: ELX) and Calumet Specialty ... the flawed logic that is rampant in the stock market. There are …
ELX-02 is a fifth-generation designer aminoglycoside optimized ... and the quotation of the Company's common stock
Eloxx’s lead product candidate, ELX-02, is a small molecule drug candidate designed ... and the quotation of the Company’s common stock on an over-the-counter securities market, as well as other factors expressed from time to …
... INFINERA CORP (INFN): Free Stock Analysis Report EXTREME NETWORKS INC (EXTR): Free Stock Analysis Report BROCADE COMMUNICATIONS SYSTEMS N (BRCD): Free Stock Analysis Report EMULEX CORP (ELX): Free …
ELX-02 in Cystic Fibrosis and Cystinosis ELX-02 is our lead ... expenses was primarily related to an increase in our …
TMCnet1mon
Details of any open stock-settled derivative positions (including traded options), or agreements to purchase or sell relevant securities, should be given on a Supplemental Form 8 (Open Positions). Where there have been dealings in more than …
Company to focus on advancing the clinical development of ELX-02, a disease-modifying therapy for genetic ... all of the issued and outstanding ordinary and preferred shares of Eloxx stock were converted, on a pro rata basis, into the right …
Eloxx’s lead product candidate, ELX-02, is a small molecule drug candidate designed ... and the quotation of the …
KHNL2mon